Docetaxel related neutropenic sepsis rate in breast cancer patients during adjuvant and neoadjuvant chemotherapy; a retrospective study

被引：0
|
作者：
Elmahdawi, N. [1 ]
Davies, M. [1 ]
Upadhyay, S. [1 ]
O'Neill, P. [1 ]
机构：
[1] Queens Ctr Oncol, Kingston Upon Hull, N Humberside, England
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70399-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [1] Rate of neutropenic sepsis in relapsed NSCLC patients receiving docetaxel chemotherapy
    Gyi, M. M.
    Gulliford, T. J.
    Muthuramalingam, S. R.
    LUNG CANCER, 2017, 103 : S41 - S42
  • [2] Neutropenic event incidence in women with early-stage breast cancer receiving neoadjuvant or adjuvant chemotherapy: a retrospective study
    Englund, Elin
    Strandeus, Michael
    Engvall, Kristina
    Oliva, Delmy
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2025,
  • [3] Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer
    Heys, SD
    Sarkar, T
    Hutcheon, AW
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (10) : 2147 - 2157
  • [4] Dose intensity and toxicity associated with Taxotere formulation: a retrospective study in a population of breast cancer patients treated with docetaxel as an adjuvant or neoadjuvant chemotherapy
    Chanat, Cedric
    Delbaldo, Catherine
    Denis, Jennifer
    Bocaccio, Francois
    Cojean-Zelek, Isabelle
    Le Guyader, Nathalie
    ANTI-CANCER DRUGS, 2015, 26 (09) : 984 - 989
  • [5] Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis
    Sirakaya, Hatice Aslan
    Inanc, Mevlude
    ERCIYES MEDICAL JOURNAL, 2020, 42 (01) : 108 - 109
  • [6] Breast cancer related lymphedema in patients received adjuvant chemotherapy containing docetaxel
    Kawada, K.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S25 - S25
  • [7] Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: A retrospective cohort study
    Axelsen, Christian Tang
    Jensen, Anders Bonde
    Jakobsen, Erik Hugger
    Bechmann, Troels
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (06) : 767 - 772
  • [8] Feasibility Study of Docetaxel with Cyclophosphamide as Adjuvant Chemotherapy for Japanese Breast Cancer Patients
    Takabatake, Daisuke
    Taira, Naruto
    Hara, Fumikata
    Sien, Tadahiko
    Kiyoto, Sachiko
    Takashima, Seiki
    Aogi, Kenjiro
    Ohsumi, Shozo
    Doihara, Hiroyoshi
    Takashima, Shigemitu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (08) : 478 - 483
  • [9] Adjuvant and neoadjuvant chemotherapy of breast cancer
    Untch, M.
    Thomssen, C.
    ONKOLOGE, 2015, 21 (03): : 231 - 238
  • [10] Adjuvant Chemotherapy with TAC (Docetaxel, Doxorubicin, and Cyclophosphamide) in Patients with Breast Cancer - Incidence of Neutropenic Fever Outside Clinical Trials
    Passos-Coelho, Jose L.
    Esteves, Susana
    Vieira, Paula A.
    Isidoro, Miguel
    Ribeiro, Manuel
    Oliveira, Joao
    Moreira, Antonio R.
    BREAST JOURNAL, 2011, 17 (05): : 539 - 541
12345